Jhpiego Company Profile

Background

Jhpiego, established in 1973 as the Johns Hopkins Program for International Education in Gynecology and Obstetrics, is a nonprofit global health organization affiliated with Johns Hopkins University. The organization is dedicated to creating and delivering transformative healthcare solutions that save lives, particularly focusing on women and families in low-resource settings. Jhpiego's mission is to ensure access to high-quality, lifesaving healthcare for all individuals, regardless of their location. Over the past five decades, Jhpiego has expanded its reach to over 150 countries, implementing programs that address a wide range of health challenges.

Key Strategic Focus

Jhpiego's strategic focus encompasses several core objectives aimed at improving global health outcomes:

• Maternal, Newborn, and Child Health: Enhancing the quality of care during pregnancy, childbirth, and the postnatal period to reduce maternal and neonatal mortality.

• Family Planning and Reproductive Health: Expanding access to contraceptive methods and reproductive health services to empower individuals in making informed choices.

• HIV/AIDS Prevention and Care: Implementing comprehensive programs for HIV prevention, testing, and treatment to curb the spread of the virus.

• Malaria Prevention and Treatment: Promoting preventive strategies and effective treatment protocols to combat malaria, especially among vulnerable populations.

• Cervical Cancer Prevention and Treatment: Introducing and scaling up screening and treatment services to detect and manage cervical cancer early.

• Infection Prevention and Control: Strengthening healthcare systems to prevent and control infections, including emerging diseases like COVID-19.

Jhpiego employs innovative approaches, such as competency-based training and the use of digital health technologies, to build the capacity of healthcare providers and systems. The organization collaborates with national governments, health experts, and local communities to tailor interventions that meet specific regional needs.

Financials and Funding

As of 2023, Jhpiego reported an annual revenue of approximately $420 million, with a significant portion derived from federal government grants, notably from the U.S. Agency for International Development (USAID). In 2024, the organization received $194 million from the federal government. Additionally, Jhpiego has secured funding from private foundations, including a $1.2 million grant from the Patrick J. McGovern Foundation in 2023. These funds are utilized to implement and expand health programs across various countries, focusing on capacity building, service delivery, and health system strengthening.

Pipeline Development

Jhpiego's programmatic initiatives are designed to address critical health issues through various stages of development and implementation:

• Maternal and Newborn Health: Through the MOMENTUM Country and Global Leadership project, Jhpiego has expanded maternal and newborn health services to over 25 countries, aligning with global frameworks such as the World Health Organization’s Ending Preventable Maternal Mortality initiative.

• Malaria Control: The organization is actively involved in global malaria control, working in 20 countries to promote preventive strategies such as the use of insecticide-treated bed nets and seasonal malaria chemoprevention. Jhpiego has also supported the rollout of the groundbreaking malaria vaccine in several West African countries.

• Cervical Cancer Prevention: Jhpiego provides technical assistance to countries for the introduction and expansion of cervical cancer prevention programs, with a focus on the Single Visit Approach, which combines screening with Visual Inspection with Acetic Acid (VIA) and offers Cryotherapy during the same visit. The organization has implemented programs in countries such as Peru, Guyana, Indonesia, Ivory Coast, Mozambique, South Africa, Tanzania, Thailand, and the Philippines.

• HIV Prevention: Jhpiego works to reduce the global burden of HIV by providing a comprehensive range of prevention services, including HIV testing, male circumcision, pre-exposure prophylaxis (PrEP), and treatment support. The organization centers communities in its care model, offering vulnerability-tailored, high-quality services that integrate biomedical, behavioral, and structural programs with connections to treatment, care, and other support services.

Technological Platform and Innovation

Jhpiego distinguishes itself through the development and implementation of innovative technologies and methodologies:

• Competency-Based Training (CBT): Pioneered in 1986, CBT emphasizes hands-on learning, ensuring healthcare providers achieve proficiency through practical experience.

• Digital Health Solutions: The organization leverages mobile learning tools, virtual mentorship, and blended education programs to build capacity in resource-limited settings. For instance, in Mozambique, Jhpiego's PI-Saude electronic patient management system enhances patient tracking and data collection, supporting HIV treatment adherence.

• Innovative Screening Tools: Jhpiego has developed low-cost, non-invasive devices for anemia screening and introduced self-injectable contraceptives, empowering women to manage their reproductive health independently.

Leadership Team

Jhpiego's leadership comprises experienced professionals dedicated to advancing global health:

• Dr. Leslie D. Mancuso, PhD, RN, FAAN: Serving as President and CEO since 2002, Dr. Mancuso has expanded Jhpiego's budget from $5 million to over $400 million and increased staff more than twenty-fold. She has been recognized with numerous awards, including the Regional Ernst & Young Entrepreneur of the Year Award and the Maryland Governor International Leadership Award.

• B. A.: Chief Executive Officer.

• G. S.: Chief Information and Technology Officer, Vice President.

• N. D.: Chief Global Engagement Officer.

Leadership Changes

As of April 2025, there have been no significant changes or appointments within Jhpiego's leadership team.

Competitor Profile

Market Insights and Dynamics

The global health sector is characterized by a collaborative environment where organizations work towards common goals of improving health outcomes in low-resource settings. The market is driven by the need for innovative, cost-effective solutions to address persistent health challenges, including maternal and child mortality, infectious diseases, and access to quality healthcare services.

Competitor Analysis

Jhpiego operates alongside several key organizations in the global health landscape:

• PATH: A global team of innovators working to accelerate health equity so all people and communities can thrive.

• EngenderHealth: Focuses on sexual and reproductive health and rights, aiming to improve access to quality healthcare services.

• JSI (John Snow, Inc.): Dedicated to improving lives through better health, education, and socioeconomic opportunities for individuals and communities.

These organizations share similar missions with Jhpiego, emphasizing capacity building, service delivery, and health system strengthening in low-resource settings.

Strategic Collaborations and Partnerships

Jhpiego's success is bolstered by strategic collaborations with various entities:

• National Governments: Partnering to develop and implement health programs tailored to specific country needs.

• Academic Institutions: Collaborating with universities, including Johns Hopkins University, to integrate research and practice.

• Private Sector: Engaging with corporations and foundations to secure funding and technical support for health initiatives.

These partnerships enhance Jhpiego's capacity to deliver comprehensive health solutions and expand its global impact.

Operational Insights

Jhpiego's operational strategy focuses on:

• Field-Based Implementation: Establishing offices in over 30 countries to ensure programs are contextually relevant and sustainable.

• Capacity Building: Training local healthcare providers to strengthen health systems from within.

• Innovation: Developing and deploying low-cost, effective health technologies and methodologies.

These approaches position Jhpiego as a leader in delivering scalable and impactful health interventions.

Strategic Opportunities and Future Directions

Looking ahead, Jhpiego aims to: